Amgen Inc. Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net
Amgen Inc. (AMGN) reported Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net of $0 for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-06.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet · last filed 2013-08-06
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2013-03-31 was $1.00M.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2012-12-31 was $0.00.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2012-09-30 was -$1.00M, a 200.00% decline year-over-year.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2012 was -$1.00M, a 200.00% decline from fiscal 2011.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2011 was $1.00M.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2010 was -$1.00M.
- Amgen Inc. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2009 was -$1.00M.
| Period end | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 3 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 6 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 9 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 12 month |
|---|---|---|---|---|
| 2013-06-30 | $0.00 10-Q · filed 2013-08-06 | $1.00M 10-Q · filed 2013-08-06 | $1.00M derived: sum of 3 quarters · filed 2013-08-06 | $0.00 derived: sum of 4 quarters · filed 2013-08-06 |
| 2013-03-31 | $1.00M 10-Q · filed 2013-05-03 | $1.00M derived: sum of 2 quarters · filed 2013-05-03 | $0.00 derived: sum of 3 quarters · filed 2013-05-03 | $1.00M derived: sum of 4 quarters · filed 2013-08-06 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$1.00M derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-08-06 | -$1.00M 10-K · filed 2013-02-27 |
| 2012-09-30 | -$1.00M 10-Q · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-08-06 | -$1.00M 10-Q · filed 2012-11-06 | -$1.00M derived: sum of 4 quarters · filed 2013-08-06 |
| 2012-06-30 | $1.00M 10-Q · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | $0.00 derived: sum of 3 quarters · filed 2013-08-06 | $1.00M derived: sum of 4 quarters · filed 2013-08-06 |
| 2012-03-31 | -$1.00M 10-Q · filed 2013-05-03 | -$1.00M derived: sum of 2 quarters · filed 2013-05-03 | $0.00 derived: sum of 3 quarters · filed 2013-05-03 | -$1.00M derived: sum of 4 quarters · filed 2013-05-03 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.00M derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | $1.00M 10-K · filed 2013-02-27 |
| 2011-09-30 | $1.00M 10-Q · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $1.00M 10-Q · filed 2012-11-06 | -$1.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | -$1.00M 10-Q · filed 2012-08-08 | -$1.00M 10-Q · filed 2012-08-08 | -$2.00M derived: sum of 3 quarters · filed 2013-02-27 | -$3.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | -$1.00M 10-Q · filed 2012-05-08 | -$1.00M derived: sum of 2 quarters · filed 2013-02-27 | -$2.00M derived: sum of 3 quarters · filed 2013-02-27 | -$1.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$1.00M derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | -$1.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | -$1.00M 10-Q · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | -$1.00M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $1.00M 10-Q · filed 2011-08-08 | $1.00M 10-Q · filed 2011-08-08 | ||
| 2010-03-31 | $1.00M 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | -$1.00M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |